Research
Energy balance
GLP-1 receptor agonist type drugs can help patients achieve considerable weight loss.
Practitioners can consider GLP-1 RAs as a treatment option for weight loss in obese patients.
StrongSupportsmedium confidence
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) type drugs have the potential to help patients achieve considerable weight loss.
Why this rating
The claim is based on the potential benefits of GLP-1 RAs as stated in the abstract.
Source
Navigating the benefits and harms of GLP-1 and GLP-1/GIP agonists in obesity
Raymond J. O’Connor · Drug and Therapeutics Bulletin · 2026
DOI 10.1136/dtb.2025.000039
reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →